Pharvaris N.V.
PHVS
$16.64
$0.080.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 42.29% | 50.33% | 40.24% | 24.77% | 14.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.50% | 50.23% | 39.17% | 33.99% | 22.76% |
| Operating Income | -51.50% | -50.23% | -39.17% | -33.99% | -22.76% |
| Income Before Tax | -42.08% | -32.85% | -25.51% | -23.68% | -33.21% |
| Income Tax Expenses | 43.03% | 73.14% | 126.79% | 169.40% | 57.80% |
| Earnings from Continuing Operations | -42.09% | -33.27% | -26.08% | -27.56% | -33.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.09% | -33.27% | -26.08% | -27.56% | -33.46% |
| EBIT | -51.50% | -50.23% | -39.17% | -33.99% | -22.76% |
| EBITDA | -51.70% | -50.40% | -39.34% | -34.06% | -22.72% |
| EPS Basic | -12.58% | 5.06% | 12.87% | 9.14% | -4.93% |
| Normalized Basic EPS | -12.51% | 5.45% | 13.33% | 11.95% | -4.81% |
| EPS Diluted | -12.58% | 5.06% | 12.87% | 9.14% | -4.93% |
| Normalized Diluted EPS | -12.51% | 5.45% | 13.33% | 11.95% | -4.81% |
| Average Basic Shares Outstanding | 25.03% | 40.78% | 43.92% | 41.78% | 28.45% |
| Average Diluted Shares Outstanding | 25.03% | 40.78% | 43.92% | 41.78% | 28.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |